TWINSTRAND BIOSCIENCES INC

formerly TwinStrand

Ultra-rare variant detection with unparalleled sensitivity

Seattle, United States · Founded 2017 · $71.5M raised

Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$71.5M
Last Round
$50.0M Series BMay 2021
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

TwinStrand Biosciences develops and commercializes Duplex Sequencing technology, which improves DNA sequencing accuracy by over 10,000-fold to detect ultra-low frequency mutations invisible by conventional NGS methods. The company serves pharmaceutical companies, clinical research networks, academic centers, and regulatory agencies across applications including residual cancer detection, genetic toxicology, and mutagenesis assay testing.

Summary

TWINSTRAND BIOSCIENCES INC is a Biotech company based in Seattle, United States, founded in 2017. It has raised $71.5M in total across 3 rounds, most recently a $50.0M Series B round in May 2021. Investors include Madrona Venture, S32 and Alexandria Venture Investments.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BMay 2021
$50.0M

Sign up to see all 3 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

TWINSTRAND BIOSCIENCES INC on Indexed.vc
<a href="https://indexed.vc/companies/twinstrand-biosciences-inc"><img src="https://indexed.vc/api/badge/company/twinstrand-biosciences-inc" alt="TWINSTRAND BIOSCIENCES INC on Indexed.vc" width="260" height="76" /></a>